Topical therapy for migraine
The invention is directed to formulations and methods of treating a migraine and/or cluster headache with a serotonin agonist, pharmaceutically acceptable salt thereof, or derivative thereof.
1. A method for treating a migraine or cluster headache comprising:
applying a topical formulation containing an effective amount of sumatriptan or a pharmaceutically acceptable salt thereof topically to the skin at the posterior cervical area of a human patient in close proximity to the brain stem, the topical formulation comprising the sumatriptan in an immediate release topical vehicle and providing rapid delivery of the sumatriptan for immediate absorption at the posterior cervical area of the human patient, to provide relief of a migraine or cluster headache which is occurring or is imminent in the patient.
2. The method of claim 1 , further comprising preparing the topical formulation as a preparation selected from the group consisting of a cream, gel, lotion, emulsion, viscous liquid, and foam.
3. The method of claim 2 , further comprising preparing the topical formulation in an aqueous based vehicle.
4. The method of claim 3 , wherein said sumatriptan is in a topical formulation selected from the group consisting of a cream, gel, lotion, emulsion, viscous liquid, and foam.
5. The method of claim 1 , wherein the patient experiences relief of the migraine or cluster headache within about 2 hours after applying the topical formulation.
6. The method of claim 1 , wherein said amount of said sumatriptan is in an amount of from about 0.5 mg to about 200 mg.
7. The method of claim 1 , wherein a unit dose of the topical formulation containing sumatriptan or a pharmaceutically acceptable salt thereof comprises from about 0.5 to about 200 mg of sumatriptan, by weight based on the succinate salt of sumatriptan, said unit dose providing relief from a migraine or cluster headache within about 2 hours after topical administration to said human patient.
8. The method of claim 1 , further comprising applying a second application of said sumatriptan to the same or different headache region within about 2 hours after applying the first application.
9. The method of claim 1 , further comprising applying the formulation to an area of intact skin in the range of about 20 cm 2 to about 60 cm 2 .
10. The method of claim 1 , further comprising reducing the side effects of said sumatriptan as compared to oral administration of said sumatriptan by applying the formulation to the posterior cervical area.
11. A method for treating a migraine or cluster headache comprising:
applying a dose of a topical formulation containing an effective amount of sumatriptan or a pharmaceutically acceptable salt thereof topically to the skin at the posterior cervical area of a human patient in close proximity to the brain stem, the topical formulation comprising the sumatriptan in an aqueous based immediate release topical vehicle and providing rapid delivery of the sumatriptan for immediate absorption at the posterior cervical area of the human patient, to provide relief of a migraine or cluster headache which is occurring or is imminent in said patient, the dose of the sumatriptan comprising from about 0.5 to about 200 mg of sumatriptan, by weight based on the succinate salt of sumatriptan, wherein the dose provides relief from a migraine or cluster headache within about 2 hours after topical administration to the human patient.
12. The method of claim 11 , wherein said sumatriptan is in a topical formulation selected from the group consisting of cream, gel, lotion, emulsion, viscous liquid, and foam.
13. The method of claim 11 , further comprising reducing the side effects of the sumatriptan as compared to oral administration of the sumatriptan by applying the formulation to the posterior cervical area.
14. The method of claim 11 , further comprising providing the dose of the sumatriptan in a metered dose device containing multiple unit doses of the sumatriptan.
15. The method of claim 11 , wherein the sumatriptan is selected from the group consisting of sumatriptan base, sumatriptan succinate, and mixtures thereof.
16. The method of claim 11 , wherein the patient experiences pain relief within less than about 30 minutes after application of the dose.
17. A method for treating a migraine or cluster headache comprising:
topically applying a dose of a topical aqueous based immediate release formulation containing from about 0.5 to about 200 mg of sumatriptan, by weight based on the succinate salt of sumatriptan, to the skin at the posterior cervical area of a human patient in close proximity to the brain stem, to provide rapid delivery of the sumatriptan for immediate absorption at the posterior cervical area of the human patient such that the dose provides relief from a migraine or cluster headache within about 2 hours after topical administration to the human patient, the topical formulation selected from the group consisting of cream, gel, lotion, emulsion, viscous liquid, and foam.